Prenatal Diagnosis

Aims & Scope

Prenatal Diagnosis welcomes submissions in all aspects of prenatal diagnosis with a particular focus on areas in which molecular biology and genetics interface with prenatal care and therapy, encompassing: all aspects of fetal imaging, including sonography and magnetic resonance imaging; prenatal cytogenetics, including molecular studies and array CGH; prenatal screening studies; fetal cells and cell-free nucleic acids in maternal blood and other fluids; preimplantation genetic diagnosis (PGD); prenatal diagnosis of single gene disorders, including metabolic disorders; fetal therapy; fetal and placental development and pathology; development and evaluation of laboratory services for prenatal diagnosis; psychosocial, legal, ethical and economic aspects of prenatal diagnosis; prenatal genetic counseling

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.7
2024	2.70

SJR (SCImago Journal Rank)

Year	Value
2024	0.932

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	110

Journal Rank

Year	Value
2024	5423

Journal Citation Indicator

Year	Value
2024	1658

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Screening for fetal aneuploidies at 11 to 13 weeks

  Citation: 489

  Authors: Kypros H.

• Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks

  Citation: 384

  Authors: Argyro, Teodora, Themistoklis, Lindsey, Kypros H.

• Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities

  Citation: 374

  Authors: Mark H., M. R., O. W.

• Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasma

  Citation: 357

  Authors: Eric, Annette, Craig, Thomas, Ken, Arnold

• Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks

  Citation: 327

  Authors: Ranjit, Argyro, Rita, Mona, Kypros H.

• The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies

  Citation: 307

  Authors: Jacob A., Glenn E., Edward M., Geralyn M., James E.

• Promises, pitfalls and practicalities of prenatal whole exome sequencing

  Citation: 304

  Authors: Sunayna, Karen, Neeta, Ignatia B., Ronald, Lyn S.

• Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast

  Citation: 302

  Authors: M., D., M., M., S., N., P. W.

• Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative european study on 52 965 amniocenteses

  Citation: 294

  Authors: M. A., J. R. W.

• Cytogenetic results from the U.S. collaborative study on CVS

  Citation: 286

  Authors: D. H., J. M., J. L., M. S., E., L., M. J., R. J., J., K. L., Y., T., S. A., A., A., A., H. A., G. G., S. E., F.

---